What is Zacks Research’s Estimate for ACHC FY2024 Earnings?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities researchers at Zacks Research lifted their FY2024 earnings per share estimates for shares of Acadia Healthcare in a report issued on Wednesday, December 18th. Zacks Research analyst Z. Masood now expects that the company will earn $3.39 per share for the year, up from their prior estimate of $3.37. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.77 EPS and Q4 2025 earnings at $0.99 EPS.

A number of other equities analysts have also recently weighed in on the company. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. StockNews.com raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price target for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. KeyCorp began coverage on Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. Finally, Royal Bank of Canada decreased their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research note on Monday, November 18th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $75.44.

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $37.90 on Monday. The stock has a market cap of $3.52 billion, a P/E ratio of 12.43, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The firm’s fifty day moving average price is $43.80 and its 200-day moving average price is $60.81.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter in the prior year, the firm posted $0.91 earnings per share. The business’s quarterly revenue was up 8.7% on a year-over-year basis.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ACHC. Wellington Management Group LLP lifted its holdings in shares of Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after purchasing an additional 1,266,384 shares in the last quarter. William Blair Investment Management LLC boosted its stake in shares of Acadia Healthcare by 20.7% in the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after buying an additional 604,070 shares during the last quarter. State Street Corp grew its holdings in shares of Acadia Healthcare by 3.5% in the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after acquiring an additional 95,613 shares during the period. Point72 Asset Management L.P. lifted its holdings in Acadia Healthcare by 0.5% in the third quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock valued at $144,753,000 after acquiring an additional 12,470 shares during the period. Finally, Geode Capital Management LLC boosted its position in Acadia Healthcare by 0.9% in the third quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock worth $102,320,000 after purchasing an additional 14,197 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.